Physician profile
Ron Gutmark
NPI 1609189893
$3,794.87
in general payments reported to CMS, 2019-2025
20 companies · $1,728 in 2025
The $1,728 reported for 2025 was more than what 87% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $55.50 · 2021: $219 · 2022: $306 · 2023: $347 · 2024: $823 · 2025: $1,728.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,898.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,189.99 | 2024-2025 | Tepezza |
| Alcon Vision LLC | $535.39 | 2019-2025 | Rocklatan, Hydrus Microstent |
| Sun Pharmaceutical Industries INC. | $531.93 | 2024-2025 | |
| Bausch & Lomb Americas INC. | $340.06 | 2022-2023 | Envista Mx60 Iol, Amvisc |
| Oyster Point Pharma, INC. | $281.41 | 2024-2025 | Tyrvaya |
| Horizon Therapeutics Plc | $155.78 | 2021-2023 | Tepezza |
| Dompe US, INC. | $154.09 | 2021-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $106.50 | 2024-2025 | Xdemvy |
| Allergan, INC. | $101.44 | 2019-2021 | |
| Thea Pharma INC. | $88.54 | 2025 | Iyuzeh |
| Rxsight INC | $75.33 | 2022-2025 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Aerie Pharmaceuticals, INC. | $46.51 | 2019-2020 | |
| Ivantis, INC | $37.89 | 2021 | |
| Harrow Eye, LLC | $29.34 | 2025 | Vevye |
| Sight Sciences, INC. | $29.28 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $27.97 | 2025 | Izervay |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $27.81 | 2019-2020 | |
| Shire North American Group INC | $22.42 | 2019 | |
| Glaukos Corporation | $13.19 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ron Gutmark listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.